פתחים סמויים מהעין

AMGN Amgen's anemia drug might have broad new uses - NY Times (53.32 )

The NY Times reports that Amgen's anemia drug might have broad new uses, recent studies have found. Laboratory and animal studies have shown that in addition to bolstering the body's red blood cells, the drug, EPO, is present in the central nervous system and acts to protect cells and tissues from damage and death. That could make it useful as a treatment for strokes, spinal cord injuries, multiple sclerosis and many other ailments. Testing in humans is in very early stages. A small study by academic scientists in Germany found that EPO, when given within eight hours of a stroke, helped protect the brain from damage and improve patient recovery. A larger trial is now under way there. Another early-stage trial in Germany is testing EPO as a treatment for schizophrenia, and in the US, academic scientists are planning trials for AIDS-related dementia and for a nerve disease similar to multiple sclerosis.